Dolby Laboratories Common Stock (DLB)
Deferred Revenue
$33.59M
Quarterly · Period ending: · USD
DLB Deferred Revenue
Latest reported$33.59Mperiod ending
Latest reported$33.59Mperiod ending
DLB Quarterly Deferred Revenue ($2.74M → $33.59M)
Quarterly deferred revenue
High-resolution chart · PNG
DLB deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 33,593,000 | |
| 38,837,000 | |
| 37,094,000 | |
| 31,382,000 | |
| 36,031,000 | |
| 39,615,000 | |
| 37,111,000 | |
| 31,644,000 | |
| 32,650,000 | |
| 37,702,000 | |
| 33,404,000 | |
| 31,505,000 | |
| 36,586,000 | |
| 22,963,000 | |
| 22,356,000 | |
| 18,588,000 | |
| 21,216,000 | |
| 22,109,000 | |
| 21,426,000 | |
| 18,473,000 | |
| 18,201,000 | |
| 20,029,000 | |
| 21,202,000 | |
| 15,436,000 | |
| 18,025,000 | |
| 19,745,000 | |
| 19,785,000 | |
| 19,991,000 | |
| 19,435,000 | |
| 20,014,000 | |
| 19,562,000 | |
| 17,468,000 | |
| 21,436,000 | |
| 22,542,000 | |
| 23,449,000 | |
| 23,150,000 | |
| 22,835,000 | |
| 23,940,000 | |
| 24,405,000 | |
| 24,180,000 | |
| 22,530,000 | |
| 22,321,000 | |
| 21,992,000 | |
| 19,284,000 | |
| 18,016,000 | |
| 16,371,000 | |
| 21,236,000 | |
| 12,496,000 | |
| 13,167,000 | |
| 12,640,000 | |
| 15,165,000 | |
| 20,931,000 | |
| 23,233,000 | |
| 20,547,000 | |
| 22,656,000 | |
| 23,493,000 | |
| 25,099,000 | |
| 26,718,000 | |
| 24,412,000 | |
| 26,701,000 | |
| 12,976,000 | |
| 10,575,000 | |
| 8,065,000 | |
| 9,647,000 | |
| 12,041,000 | |
| 17,290,000 | |
| 28,294,000 | |
| 37,204,000 | |
| 35,110,000 | |
| 25,372,000 | |
| 39,481,000 | |
| 37,344,000 | |
| 30,894,000 | |
| 24,594,000 | |
| 18,358,000 | |
| 13,522,000 | |
| 11,927,000 | |
| 10,350,000 | |
| 7,559,000 | |
| 6,358,000 | |
| 5,701,000 | |
| 4,558,000 | |
| 5,121,000 | |
| 3,268,000 | |
| 2,865,000 | |
| 2,544,000 | |
| 2,355,000 | |
| 2,562,000 | |
| 2,736,000 |